PEARLPAK Trademark

Trademark Overview

On Friday, October 21, 2022, a trademark application was filed for PEARLPAK with the United States Patent and Trademark Office. The USPTO has given the PEARLPAK trademark a serial number of 97642821. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by CleopatraRX Development LLC. The PEARLPAK trademark is filed in the Pharmaceutical Products category with the following description:

Daily oral pills, sold in a package that marks the pills' dosage, for the treatment of perimenopause, menopause and post-menopause symptoms
pearlpak

General Information

Serial Number97642821
Word MarkPEARLPAK
Filing DateFriday, October 21, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements

Goods and ServicesDaily oral pills, sold in a package that marks the pills' dosage, for the treatment of perimenopause, menopause and post-menopause symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code005
First Use Anywhere DateFriday, July 31, 2020
First Use In Commerce DateFriday, April 30, 2021

Trademark Owner History

Party NameCleopatraRX Development LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTulsa, TX 74119
Party NameCleopatraRX Development LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTulsa, TX 74119

Trademark Events

Event DateEvent Description
Tuesday, October 25, 2022NEW APPLICATION ENTERED
Sunday, November 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 4, 2023ASSIGNED TO EXAMINER
Friday, August 4, 2023NON-FINAL ACTION WRITTEN
Friday, August 4, 2023NON-FINAL ACTION E-MAILED
Friday, August 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2024NON-FINAL ACTION WRITTEN
Thursday, March 21, 2024NON-FINAL ACTION E-MAILED
Thursday, March 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 2, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, August 13, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 13, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 13, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 13, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

pearlpak menopause pills perimenopause symptoms post treatment marks oral sold package